Skip to main content

Advertisement

Table 2 Clinical and Biochemical Characteristics of the non-NASH Patients and NASH Patients

From: Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH)

  Non-NASH patients NASH patients P value
Age (years) 49.0 ± 15.3 52.8 ± 13.5 0.2995
BMI (m/kg2) 27.6 ± 5.1 28.9 ± 6.0 0.3989
VFA (cm2) 128.6 ± 55.7 133.3 ± 58.8 0.8031
SFA (cm2) 196.9 ± 61.4 232.5 ± 120.9 0.3765
AST (U/ml) 35.7 ± 17.5 63.4 ± 40.7 0.0031
ALT (U/ml) 56.8 ± 31.5 89.9 ± 55.7 0.0115
FBS (mg/dl) 118.7 ± 39.9 118.2 ± 30.8 0.9586
IRI (ul/ml) 13.6 ± 10.8 14.3 ± 8.2 0.7999
HOMA-IR 3.47 ± 2.64 4.05 ± 2.54 0.4725
HDL cholesterol (mg/l) 50.3 ± 12.6 49.3 ± 11.4 0.7463
LDL cholesterol (mg/l) 133.7 ± 27.0 128.6 ± 39.3 0.5928
Triglyceride (mg/l) 159.0 ± 48.9 162.8 ± 81.9 0.8502
Albumin 4.51 ± 0.28 4.45 ± 0.51 0.6175
Platelet count 25.8 ± 5.7 23.2 ± 8.0 0.1816
Hyaluronic acid (ng/dl) 21.6 ± 15.1 50.1 ± 50.2 0.0373
Type IV collagen 7s (ng/dl) 4.41 ± 0.98 5.14 ± 1.31 0.0611
  1. Data are expressed as means ± SD. VFA: visceral fat area, SFA: subcutaneous fat area, AST: aspartate aminotransferase, ALT: alanine aminotransferase, FBS: fasting blood sugar, IRI: immunoreactive insulin, HOMA-IR: homeostasis model assessment of insulin resistance.